[go: up one dir, main page]

DK1143917T3 - Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom - Google Patents

Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom

Info

Publication number
DK1143917T3
DK1143917T3 DK99951502T DK99951502T DK1143917T3 DK 1143917 T3 DK1143917 T3 DK 1143917T3 DK 99951502 T DK99951502 T DK 99951502T DK 99951502 T DK99951502 T DK 99951502T DK 1143917 T3 DK1143917 T3 DK 1143917T3
Authority
DK
Denmark
Prior art keywords
convulsive
post
stress disorder
treatment
traumatic stress
Prior art date
Application number
DK99951502T
Other languages
English (en)
Inventor
Kammen Daniel P Van
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1143917T3 publication Critical patent/DK1143917T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
DK99951502T 1998-11-17 1999-10-12 Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom DK1143917T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10880598P 1998-11-17 1998-11-17
PCT/US1999/021612 WO2000028945A2 (en) 1998-11-17 1999-10-12 Anticonvulsant derivatives useful in treating post traumatic stress disorder

Publications (1)

Publication Number Publication Date
DK1143917T3 true DK1143917T3 (da) 2004-06-01

Family

ID=22324143

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99951502T DK1143917T3 (da) 1998-11-17 1999-10-12 Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom

Country Status (15)

Country Link
US (1) US6472370B1 (da)
EP (1) EP1143917B1 (da)
CN (1) CN1326346A (da)
AT (1) ATE261724T1 (da)
AU (1) AU764510B2 (da)
BR (1) BR9915434A (da)
CA (1) CA2351658C (da)
DE (1) DE69915690T2 (da)
DK (1) DK1143917T3 (da)
ES (1) ES2217819T3 (da)
HU (1) HUP0105037A3 (da)
NO (1) NO20012423D0 (da)
NZ (1) NZ511881A (da)
PT (1) PT1143917E (da)
WO (1) WO2000028945A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01012187A (es) * 1999-05-28 2002-06-21 Jeffrey Berlant Compuestos y metodos para el tratamiento del trastorno por estres postraumatico.
CA2430010A1 (en) * 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
SI1539157T1 (sl) 2002-09-18 2013-11-29 Trustees Of The University Of Pennsylvania Rapamicin za uporabo pri inhibiciji ali preprečevanju horoidalne neovaskularizacije
CN102144961A (zh) 2003-09-18 2011-08-10 参天制药株式会社 经巩膜递送
KR101387456B1 (ko) 2005-02-09 2014-04-21 산텐 세이야꾸 가부시키가이샤 질환 또는 상태의 치료를 위한 액체 제제
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
CN101443004B (zh) 2006-03-23 2013-03-06 参天制药株式会社 用于与血管通透性有关的疾病或病症的制剂
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5753693A (en) * 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder

Also Published As

Publication number Publication date
DE69915690T2 (de) 2005-02-24
AU764510B2 (en) 2003-08-21
EP1143917A2 (en) 2001-10-17
WO2000028945A2 (en) 2000-05-25
CA2351658C (en) 2006-07-11
EP1143917B1 (en) 2004-03-17
DE69915690D1 (de) 2004-04-22
EP1143917A3 (en) 2002-01-02
BR9915434A (pt) 2001-12-04
NO20012423L (no) 2001-05-16
NZ511881A (en) 2004-12-24
WO2000028945A3 (en) 2001-09-20
CA2351658A1 (en) 2000-05-25
PT1143917E (pt) 2004-06-30
AU6393399A (en) 2000-06-05
HUP0105037A2 (hu) 2002-04-29
US6472370B1 (en) 2002-10-29
ES2217819T3 (es) 2004-11-01
CN1326346A (zh) 2001-12-12
ATE261724T1 (de) 2004-04-15
HUP0105037A3 (en) 2003-01-28
NO20012423D0 (no) 2001-05-16

Similar Documents

Publication Publication Date Title
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
DE60010098D1 (de) 28-epirapaloge
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
DE69525369D1 (de) Kontinuierliches polymerisationverfahren von polyamiden
DE69713347D1 (de) Flammbehandlungsverfahren
DK0937016T3 (da) Behandling af kulbrintegas
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
DK0912535T3 (da) Konjugater af cis-docosahexaensyre og paclitaxel
DK0830864T3 (da) Kombinationsbehandling til behandling af psykoser
DE69627659D1 (de) Neue thrombin-inhibitoren, deren herstellung und verwendung
DE69935468D1 (de) Erzeugen von Nachrichtensignalen
DE69733470D1 (de) Laserbearbeitung
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
DE69907803D1 (de) Laserbehandlungsgerät
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
DK0948888T3 (da) System til behandling af gødning
PE20399A1 (es) Muteina ob
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
DE59702263D1 (de) Reinigung von p.p-Bisphenolat-Lösungen
DE59908316D1 (de) Schleifen von garnituren
IT1284920B1 (it) Trattamento del diamante
ID16843A (id) Alat pembersih.
NL1001157A1 (nl) Zuiveringsinstallatie.